50
Views
18
CrossRef citations to date
0
Altmetric
Original

Induction of oxidative cell damage by photo-treatment with zinc metaN-methylpyridylporphyrin

, , , &
Pages 89-96 | Received 21 May 2006, Published online: 07 Jul 2009
 

Abstract

We have previously reported that isomeric Zn(II) N-methylpyridylporphyrins (ZnTM-2(3,4)-PyP4 + ) can act as photosensitizers with efficacy comparable to that of hematoporphyrin derivative (HpD) in preventing cell proliferation and causing cell death in vitro. To better understand the biochemical basis of this activity, the effects of photo-activated ZnTM-3-PyP4 + on GSH/GSSG ratio, lipid peroxidation, membrane permeability, oxidative DNA damage, and the activities of SOD, catalase, glutathione reductase, and glutathione peroxidase were evaluated. Light exposure of ZnTM-3-PyP4 + -treated colon adenocarcinoma cells caused a wide spectrum of oxidative damage including depletion of GSH, inactivation of glutathione reductase and glutathione peroxidase, oxidative DNA damage and peroxidation of membrane lipids. Cell staining with Hoechst-33342 showed morphological changes consistent with both necrotic and apoptotic death sequences, depending upon the presence of oxygen.

Abbreviations
ZnTM-3-PyP4 + =

meta isomer, Zn(II) tetrakis(N-methylpyridinium-3-yl)porphyrin

PDT=

photodynamic therapy

HpD=

hematoporphyrin derivative

SOD=

superoxide dismutase

MDA=

malondialdehyde

8-OHdG=

8-hydroxy-2′-deoxyguanosine

ROS=

reactive oxygen species

RNS=

reactive nitrogen species

ANOVA=

analysis of variance

Abbreviations
ZnTM-3-PyP4 + =

meta isomer, Zn(II) tetrakis(N-methylpyridinium-3-yl)porphyrin

PDT=

photodynamic therapy

HpD=

hematoporphyrin derivative

SOD=

superoxide dismutase

MDA=

malondialdehyde

8-OHdG=

8-hydroxy-2′-deoxyguanosine

ROS=

reactive oxygen species

RNS=

reactive nitrogen species

ANOVA=

analysis of variance

Notes

M. Alkhalaf, Department of Biochemistry, Faculty of Medicine, Kuwait University—personal communication.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.